Wyatt McDonnell of Infinimmune shares insight on human-first models and what the FDA's policy shift means for biotech R&D.

Parexel, a clinical research organization (CRO), has appointed Charlotte Moser, MD, PhD, MBA as Chief Medical Officer.

Galapagos NV, a global biotechnology company, announced the departure of its CFO and COO, Thad Huston, effective as of August 1, 2025. The company expects to announce Huston’s successor in the coming ...

Boehringer Ingelheim and Cue Biopharma Inc. have joined forces to develop and commercialize Cue Biopharma’s CUE-501 product candidate.

The U.S. Food and Drug Administration has designated Celltrion Inc.’s YUFLYMA (adalimumab-aaty), as an interchangeable biosimilar to Humira.

Vanessa Zann and Andrew Parker share insights on poorly soluble APIs, approaches for modified release formulation development, and navigating accelerated approval pathways.

Cyprumed G mbH, a drug delivery company specializing in oral peptide formulations and MSD, have signed a Non-Exclusive License and Option Agreement to develop oral formulations of MSD’s peptides using ...

Meribel Pharma Solutions, a new mid-sized CDMO, has launched with an extensive integrated network across Europe.

The CCT Tower Elite provides a singular solution for pharmaceutical companies looking to ship large consignments globally.

Thermo Fisher Scientific Inc. has introduced the 5L DynaDrive Single-Use Bioreactor, expanding the company's portfolio of ...

Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has appointed Thomas ...

Lonza will serve as a CMAC Translation to Industry Collaborator, reinforcing its commitment to advancing innovative ...